Latest News - Tata Motors

Top Corporates Hub

Tata Motors

TATAMOTORS | NSE | India
999
-40
Rank
$0.00B
Market Cap
$52.33B
+$ 1.43B
+2.81%
Revenue
$3.82B
+$ 1B
+35.46%
Earnings
86.3K
+26.1K
+43.5%
Employees
What Altria Group (MO)'s Higher 2026 Earnings Outlook Means For Shareholders

22.08.2026 09:07

In the past few days, Altria Group released its second-quarter results, reporting year-over-year adjusted earnings growth even though it missed consensus estimates and continues to face declining U.S. cigarette volumes and uneven oral tobacco performance. Management also raised the lower end of its 2026 earnings outlook, highlighting pricing power, margin gains, and cigarette import/export benefits as key supports for future profit resilience despite product mix and volume headwinds. Now,...

Read More

Altria (NYSE:MO) Passes Best Dividend Screen With a 6.26% Yield and Strong Profitability

13.08.2026 09:50

Altria (MO) passes Best Dividend screen with 6.26% yield, strong profitability, and dividend rating 7, though high payout ratio signals caution.

Read More

Altria Group expands On! Plus distribution

04.08.2026 11:00

The nicotine pouch brand, which received marketing approval from the FDA for multiple varieties in late 2025, expanded to 120,000 stores nationwide.

Read More

Altria (MO) Q2 2026 Earnings Call Transcript

04.08.2026 00:15

EPS grew 2.8% as Marlboro pricing offset volume declines and oral tobacco expanded.

Read More

Altria Group (MO) Faces Investigation Over On! PLUS FDA Disclosure Claims

02.08.2026 09:10

Levi & Korsinsky has opened an investigation into Altria Group regarding disclosures tied to the FDA regulatory status of its on! PLUS nicotine pouch product. The review focuses on whether Altria accurately described near term FDA authorization prospects for on! PLUS in its public statements. This action introduces an additional legal and regulatory consideration for investors following NYSE:MO. Altria Group, trading under NYSE:MO, now faces questions around its communication practices at a...

Read More

MO Q2 Deep Dive: Margin Pressure Amid Consumer Strain and Smoke-Free Investments

01.08.2026 04:51

Tobacco company Altria (NYSE:MO) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.2% year on year to $5.36 billion. Its non-GAAP profit of $1.48 per share was 1.2% below analysts’ consensus estimates.

Read More

Altria (MO) Q2 2026 Earnings Call Transcript

31.07.2026 00:30

EPS grew 2.8% as Marlboro pricing offset volume declines and oral tobacco expanded.

Read More

Which S&P500 stocks are moving on Thursday?

30.07.2026 16:35

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Read More

Altria Shares Decline After Earnings Miss and Narrowed Full-Year Outlook

30.07.2026 13:53

Altria Group Inc. (NYSE:MO) shares fell nearly 4% after the tobacco company reported second-quarter earnings that came in slightly below Wall Street expectations, despite revenue exceeding forecasts.

Read More

Altria (MO) Reports Q2 Earnings: What Key Metrics Have to Say

30.07.2026 13:30

The headline numbers for Altria (MO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Read More

Altria (NYSE:MO) Posts Better-Than-Expected Sales In Q2 CY2026

30.07.2026 12:57

Tobacco company Altria (NYSE:MO) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 15.5% year on year to $6.11 billion. Its non-GAAP profit of $1.48 per share was 1.2% below analysts’ consensus estimates.

Read More

Altria (MO) Q2 Earnings and Revenues Lag Estimates

30.07.2026 12:35

Altria (MO) delivered earnings and revenue surprises of -1.33% and -0.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Read More

Altria Group (NYSE:MO) Q2 Earnings and Revenue Miss Send Shares Lower

30.07.2026 12:34

Altria (MO) shares fell 3.2% after Q2 earnings and revenue missed estimates. Full-year guidance was narrowed below consensus, pressured by weak premium demand.

Read More

Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance

30.07.2026 11:00

RICHMOND, Va., July 30, 2026--Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance

Read More

Altria Group Raises FY2026 Adj EPS Guidance from $5.56-$5.72 to $5.61-$5.72 vs $5.69 Est

30.07.2026 07:04

Altria Group (NYSE:MO) raises FY2026 Adj EPS guidance from $5.56-$5.72 to $5.61-$5.72 vs $5.69 analyst estimate..

Read More

Altria Group Q2 Adj. EPS $1.48 Misses $1.50 Estimate, Sales $6.111B Beat $5.346B Estimate

30.07.2026 07:00

Altria Group (NYSE:MO) reported quarterly earnings of $1.48 per share which missed the analyst consensus estimate of $1.50 by 1.33 percent. This is a 2.78 percent increase over earnings of $1.44 per share from the same

Read More

Can Altria Group (MO) Still Be Undervalued After The FDA Proposal?

29.07.2026 04:28

Altria Group stock has delivered strong long term gains over the past five years, while current valuation checks and an intrinsic value estimate from a Discounted Cash Flow (DCF) approach both point to the shares trading at a discount to their estimated worth. That combination raises the question of whether the market is still underpricing the company after such a solid run. Altria Group has returned 130.4% over the past five years, which puts recent pricing in the context of a sustained...

Read More

4 High Shareholder Yield Stocks to Buy Amid Rising Uncertainty

28.07.2026 13:42

Amid rising market uncertainty, HSBC, MO, AMG and IIPR stand out for their strong shareholder yields, supported by dividends, share buybacks and debt reduction.

Read More

What Should You Do With DVY At A New High?

28.07.2026 00:55

The dividend ETF just hit a record, and while it feels like a moment to act, the data suggests a different kind of discipline.

Read More